Suvecaltamide clinical trials
Also written CX-8998 and JZP385.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2009
How each study uses suvecaltamide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2009 (1)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 6
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 0
Studies
Open first, then newest update. How each study uses suvecaltamide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's DiseaseCompletedPhase 2Jazz PharmaceuticalsNCT05642442Written as Suvecaltamide
- A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET)CompletedPhase 2Jazz PharmaceuticalsNCT05122650Written as JZP385
- CX-8998 for Absence SeizuresCompletedPhase 2Jazz PharmaceuticalsNCT03406702Written as CX-8998
- A Phase 2 RCT Study of CX-8998 for Essential TremorCompletedPhase 2Jazz PharmaceuticalsNCT03101241Written as CX-8998
- A Phase 2 Study of CX-8998 in Adults With Tremor Associated With Parkinson's DiseaseWithdrawnPhase 2Jazz PharmaceuticalsNCT03436953Written as CX-8998
- A Study to Test the Safety and Efficacy of MK-8998 in Acutely Psychotic Participants With Schizophrenia (MK-8998-004)CompletedPhase 2Merck Sharp & Dohme LLCNCT00827918Written as MK-8998
Codes
What other systems call suvecaltamide · ClinicalTrials.gg INT017301
- UNII (FDA) MIA4WMP8QNSUVECALTAMIDEOne source FDA
- NCI Thesaurus C174710SuvecaltamideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | MIA4WMP8QN | SUVECALTAMIDE | One source FDA |
| NCI Thesaurus | C174710 | Suvecaltamide | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.